236 related articles for article (PubMed ID: 38578405)
1. Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract][Full Text] [Related]
2. Overcoming delivery barriers in immunotherapy for glioblastoma.
Rui Y; Green JJ
Drug Deliv Transl Res; 2021 Dec; 11(6):2302-2316. PubMed ID: 34053034
[TBL] [Abstract][Full Text] [Related]
3. Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers.
Turk OM; Woodall RC; Gutova M; Brown CE; Rockne RC; Munson JM
Drug Deliv Transl Res; 2021 Dec; 11(6):2448-2467. PubMed ID: 34718958
[TBL] [Abstract][Full Text] [Related]
4. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
Lim SH; Yee GT; Khang D
Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
9. Novel delivery strategies for glioblastoma.
Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
[TBL] [Abstract][Full Text] [Related]
10. Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward.
Smith EJ; Naik A; Goel M; Wen PY; Lim M; Chang SM; Germano IM
Neurooncol Adv; 2024; 6(1):vdad169. PubMed ID: 38312230
[TBL] [Abstract][Full Text] [Related]
11. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Youssef G; Wen PY
Curr Neurol Neurosci Rep; 2024 Feb; 24(2):17-25. PubMed ID: 38170429
[TBL] [Abstract][Full Text] [Related]
12. Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Subbiah V; Kreitman RJ; Wainberg ZA; Gazzah A; Lassen U; Stein A; Wen PY; Dietrich S; de Jonge MJA; Blay JY; Italiano A; Yonemori K; Cho DC; de Vos FYFL; Moreau P; Fernandez EE; Schellens JHM; Zielinski CC; Redhu S; Boran A; Passos VQ; Ilankumaran P; Bang YJ
Nat Med; 2023 May; 29(5):1103-1112. PubMed ID: 37059834
[TBL] [Abstract][Full Text] [Related]
13. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Liau LM; Ashkan K; Brem S; Campian JL; Trusheim JE; Iwamoto FM; Tran DD; Ansstas G; Cobbs CS; Heth JA; Salacz ME; D'Andre S; Aiken RD; Moshel YA; Nam JY; Pillainayagam CP; Wagner SA; Walter KA; Chaudhary R; Goldlust SA; Lee IY; Bota DA; Elinzano H; Grewal J; Lillehei K; Mikkelsen T; Walbert T; Abram S; Brenner AJ; Ewend MG; Khagi S; Lovick DS; Portnow J; Kim L; Loudon WG; Martinez NL; Thompson RC; Avigan DE; Fink KL; Geoffroy FJ; Giglio P; Gligich O; Krex D; Lindhorst SM; Lutzky J; Meisel HJ; Nadji-Ohl M; Sanchin L; Sloan A; Taylor LP; Wu JK; Dunbar EM; Etame AB; Kesari S; Mathieu D; Piccioni DE; Baskin DS; Lacroix M; May SA; New PZ; Pluard TJ; Toms SA; Tse V; Peak S; Villano JL; Battiste JD; Mulholland PJ; Pearlman ML; Petrecca K; Schulder M; Prins RM; Boynton AL; Bosch ML
JAMA Oncol; 2023 Jan; 9(1):112-121. PubMed ID: 36394838
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
